Jumping ship — Allegan's COO resigns: 4 insights

Written by Eric Oliver | December 20, 2017 | Print  |

Allergan's COO Robert Stewart resigned from the company to become president and CEO of Amneal Pharmaceuticals starting Jan. 25, 2018, Orange County Business Journal reports.

Here's what you should know:

1. Allergan appointed Wayne Swanton, the company's vice president of global operations, its new COO.

2. Mr. Stewart will oversee Amneal and its pending merger with Impax Laboratories. The acquisition will close in the first half of 2018.

3. Mr. Stewart will also join the resulting combined company's new board.

4. Allergan's CFO Teresa Hilado also recently announced her plans to retire. She's staying with Allergan until a successor is found.

More articles on leadership:
Surgery Center of Oklahoma receives Michelle Malkin Investigates Bull Dog Award: 5 key notes
ASCA sees nearly 200 new members in 2017
Gastro Health's Dr. Eduardo Krajewski is West Kendall Baptist Hospital's 2017 Physician of the Year — 3 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.